Estradiol/progesterone - Watson
Alternative Names: Progesterone/estradiolLatest Information Update: 05 Dec 2021
At a glance
- Originator Watson Pharmaceuticals
- Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnenediones
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 31 Dec 2002 Discontinued - Phase-III for Menopausal syndrome in USA (PO)
- 19 Mar 2002 Phase-III clinical trials in Menopausal syndrome in USA (PO)